You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

PREVACID NAPRAPAC 250 (COPACKAGED) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Prevacid Naprapac 250 (copackaged) patents expire, and when can generic versions of Prevacid Naprapac 250 (copackaged) launch?

Prevacid Naprapac 250 (copackaged) is a drug marketed by Takeda Pharms Na and is included in one NDA.

The generic ingredient in PREVACID NAPRAPAC 250 (COPACKAGED) is lansoprazole; naproxen. There are fifty-six drug master file entries for this compound. Additional details are available on the lansoprazole; naproxen profile page.

US Patents and Regulatory Information for PREVACID NAPRAPAC 250 (COPACKAGED)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Na PREVACID NAPRAPAC 250 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-002 Nov 14, 2003 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for PREVACID NAPRAPAC 250 (COPACKAGED)

See the table below for patents covering PREVACID NAPRAPAC 250 (COPACKAGED) around the world.

Country Patent Number Title Estimated Expiration
Spain 546152 ⤷  Try a Trial
Hungary T39444 ⤷  Try a Trial
Latvia 5775 Piridina atvasinajumi un to iegusanas panemiens ⤷  Try a Trial
Canada 1327010 COMPOSITIONS PHARMACEUTIQUES CONTENANT UN COMPOSE ANTI-ULCEREUX DE TYPE BENZIMIDAZOLE ET SA PRODUCTION (STABILIZED SOLID PHARMACEUTICAL COMPOSITION CONTAINING ANTIULCER BENZIMIDAZOLE COMPOUND AND ITS PRODUCTION) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for PREVACID NAPRAPAC 250 (COPACKAGED)

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0174726 SPC/GB94/011 United Kingdom ⤷  Try a Trial SPC/GB94/011, EXPIRES: 20051210
0174726 93C0021 Belgium ⤷  Try a Trial PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.